Enhanced Cellular Immune Responses Elicited by an Engineered HIV-1 Subtype B Consensus-based Envelope DNA Vaccine
Open Access
- 1 February 2007
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 15 (2) , 411-421
- https://doi.org/10.1038/sj.mt.6300036
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Cross-Subtype T-Cell Immune Responses Induced by a Human Immunodeficiency Virus Type 1 Group M Consensus Env ImmunogenJournal of Virology, 2006
- Immunogenicity Testing of a Novel Engineered HIV-1 Envelope Gp140 DNA Vaccine ConstructDNA and Cell Biology, 2006
- Identification of Two N-Linked Glycosylation Sites within the Core of the Simian Immunodeficiency Virus Glycoprotein Whose Removal Enhances Sensitivity to Soluble CD4Journal of Virology, 2005
- The quest for an AIDS vaccine: is the CD8+ T-cell approach feasible?Nature Reviews Immunology, 2002
- CD4 Independence of Simian Immunodeficiency Virus Envs Is Associated with Macrophage Tropism, Neutralization Sensitivity, and Attenuated PathogenicityJournal of Virology, 2002
- Induction of Potent Th1‐Type Immune Responses from a Novel DNA Vaccine for West Nile Virus New York Isolate (WNV‐NY1999)The Journal of Infectious Diseases, 2001
- Relationships between CD4 Independence, Neutralization Sensitivity, and Exposure of a CD4-Induced Epitope in a Human Immunodeficiency Virus Type 1 Envelope ProteinJournal of Virology, 2001
- Increased Neutralization Sensitivity of CD4-Independent Human Immunodeficiency Virus VariantsJournal of Virology, 2001
- Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cellsThe Lancet, 1995
- Transmission and Pathogenesis of Human Immunodeficiency Virus Type 1AIDS Research and Human Retroviruses, 1994